APPLICATION
ANDA209097
TYPE
ANDA
ORIGINAL APPROVAL
2019-02-22
LATEST ACTION
2024-10-11
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
METHYLPREDNISOLONEDiscontinued
METHYLPREDNISOLONE 32MG · TABLET · ORAL
METHYLPREDNISOLONEDiscontinued
METHYLPREDNISOLONE 8MG · TABLET · ORAL
METHYLPREDNISOLONEDiscontinued
METHYLPREDNISOLONE 2MG · TABLET · ORAL
METHYLPREDNISOLONEDiscontinued
METHYLPREDNISOLONE 16MG · TABLET · ORAL
METHYLPREDNISOLONEDiscontinued
METHYLPREDNISOLONE 4MG · TABLET · ORAL
Approval history
2024-10-11Labeling · Supplement 1 · standardAP
2019-02-22UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.